journal article·2016-04

Folic‐Acid‐Mediated Functionalized Gold Nanocages for Targeted Delivery of Anti‐miR‐181b in Combination of Gene Therapy and Photothermal Therapy against Hepatocellular Carcinoma

Shengnan Huang, Shaofeng Duan, Jing Wang, Shijin Bao, Xiaojing Qiu, Chunming Li, Ying Liu, Lijuan Yan, Zhenzhong Zhang, Yurong Hu

Advanced Functional Materials· Volume 26· Issue 15
Publisher page

Abstract

Therapeutic strategies based on modulation of microRNAs (miRNAs) activity hold much promise for cancer therapy, but for clinical applications, the efficient delivery of miRNAs to tumor cells or tumor tissues remains a great challenge. In this work, microRNA‐181b inhibitor (anti‐miR‐181b) is successfully condensed into polyethyleneimine (PEI)‐modified and folate receptor (FR)‐targeted PEGylated gold nanocages (AuNCs). This delivery system is designated as anti‐miR‐181b/PTPAuNCs nanocomplexes (PTPAuNC‐NPs), which begin with chemical modification of AuNCs with SH‐PEG5000‐folic acid (SH‐PEG5000‐FA) and SH‐PEG5000 through a gold–sulfur bond, followed by conjugating PEI using lipoic acid as a linker. Finally anti‐miR‐181b is condensed via electrostatic interactions. In vitro and in vivo experiments show that PTPAuNC‐NPs can efficiently deliver anti‐miR‐181b into target sites to suppress tumor growth, and considerably decrease tumor volumes in SMMC‐7721 tumor‐bearing nude mice under near‐infrared radiation. All these results suggest that PTPAuNC‐NP gene delivery system with combination of gene therapy and photothermal therapy will be of great potential use in future cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · MicroRNA in disease regulation · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmaceutical Sciences Zhengzhou University 100 Kexue Avenue Zhengzhou 450001 P. R. China

The First Affiliated Hospital of Zhengzhou University 1 Construction Road Zhenzhong 450052 P. R. China

Department of Pharmacy Yanzhou People's Hospital 99 Jianshe xi Road Jining 272100 P. R. China

Collaborative Innovation Center of New Drug Research and Safety Evaluation Henan Province Zhengzhou 450001 P. R. China

Academy of Medical Science Zhengzhou University Zhengzhou 450052 P. R. China

Funding

National Natural Science Foundation of China

References (49)

Show source-provided references
1. Ma L. · Discovery Med. · 2015 · 19 · 7
2. 10.1016/j.jhep.2011.07.00710.1016/j.jhep.2011.07.007 ↗
3. Farazi P. A. · Discovery Med. · 2006 · 6 · 182
4. 10.1038/clpt.2012.19210.1038/clpt.2012.192 ↗
5. 10.1038/onc.2008.27410.1038/onc.2008.274 ↗
6. 10.1158/0008-5472.CAN-11-114410.1158/0008-5472.CAN-11-1144 ↗
7. 10.1002/hep.2672010.1002/hep.26720 ↗
8. 10.1371/journal.pone.007965510.1371/journal.pone.0079655 ↗
9. 10.1093/carcin/bgs13010.1093/carcin/bgs130 ↗
10. 10.1038/onc.2009.46810.1038/onc.2009.468 ↗
11. 10.1016/j.addr.2014.05.00910.1016/j.addr.2014.05.009 ↗
12. 10.1016/j.bbrc.2006.12.13510.1016/j.bbrc.2006.12.135 ↗
13. 10.1038/nature0479110.1038/nature04791 ↗
14. 10.1038/nrc296610.1038/nrc2966 ↗
15. 10.1016/j.jconrel.2013.09.01510.1016/j.jconrel.2013.09.015 ↗
16. 10.1016/j.addr.2014.10.03110.1016/j.addr.2014.10.031 ↗
17. 10.1038/mt.2012.6710.1038/mt.2012.67 ↗
18. 10.1016/j.biomaterials.2012.12.01610.1016/j.biomaterials.2012.12.016 ↗
19. 10.1016/j.biomaterials.2013.11.03910.1016/j.biomaterials.2013.11.039 ↗
20. 10.1016/j.addr.2012.05.00410.1016/j.addr.2012.05.004 ↗
21. 10.1021/nn800370j10.1021/nn800370j ↗
22. 10.1016/j.addr.2010.03.01110.1016/j.addr.2010.03.011 ↗
23. 10.1038/nature1232710.1038/nature12327 ↗
24. 10.3109/1061186X.2014.93140510.3109/1061186X.2014.931405 ↗
25. 10.1016/j.biomaterials.2014.12.03510.1016/j.biomaterials.2014.12.035 ↗
26. 10.1016/j.biomaterials.2014.12.02010.1016/j.biomaterials.2014.12.020 ↗
27. 10.1016/j.biomaterials.2014.12.04010.1016/j.biomaterials.2014.12.040 ↗
28. 10.1007/s10555-008-9155-610.1007/s10555-008-9155-6 ↗
29. 10.1038/nprot.2007.32610.1038/nprot.2007.326 ↗
30. 10.1002/adfm.20140228910.1002/adfm.201402289 ↗
31. 10.1016/j.jconrel.2010.02.00510.1016/j.jconrel.2010.02.005 ↗
32. 10.1016/j.biomaterials.2014.08.02210.1016/j.biomaterials.2014.08.022 ↗
33. 10.1038/nprot.2008.24310.1038/nprot.2008.243 ↗
34. 10.1002/adhm.20140002610.1002/adhm.201400026 ↗
35. 10.1016/j.biomaterials.2012.09.03710.1016/j.biomaterials.2012.09.037 ↗
36. 10.1016/j.jcis.2011.09.01310.1016/j.jcis.2011.09.013 ↗
37. 10.1073/pnas.72.3.93710.1073/pnas.72.3.937 ↗
38. 10.1021/nn900215k10.1021/nn900215k ↗
39. 10.1038/gt.2010.11710.1038/gt.2010.117 ↗
40. 10.1016/j.bbamem.2012.07.01110.1016/j.bbamem.2012.07.011 ↗
41. Bahmani B. · Int. J. Nanomed. · 2013 · 8 · 1609
42. 10.1021/bc100308p10.1021/bc100308p ↗
43. 10.1021/ja412735p10.1021/ja412735p ↗
44. 10.4155/tde.11.7210.4155/tde.11.72 ↗
45. 10.1021/ar200061q10.1021/ar200061q ↗
46. 10.1002/adfm.20100132910.1002/adfm.201001329 ↗
47. Fu M. · Int. J. Clin. Exp. Pathol. · 2013 · 6 · 2185
48. 10.1371/journal.pone.009993210.1371/journal.pone.0099932 ↗
49. 10.1021/nn303022310.1021/nn3030223 ↗